Peter Traber
Directeur/Bestuurslid bij Baylor College of Medicine
Vermogen: 110 791 $ op 30-04-2024
Actieve functies van Peter Traber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Baylor College of Medicine | Directeur/Bestuurslid | 01-01-2008 | - |
| Algemeen Directeur | 01-01-2003 | 01-01-2008 |
Loopbaan van Peter Traber
Eerdere bekende functies van Peter Traber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-03-2020 | 13-11-2023 |
| Alacrita Consulting Ltd. | Corporate Officer/Principal | 01-07-2018 | 01-08-2020 |
| GALECTIN THERAPEUTICS INC. | Directeur/Bestuurslid | 12-02-2009 | 14-12-2017 |
| Algemeen Directeur | 23-03-2011 | 06-07-2018 | |
| Hoofd Techniek/Wetenschap/O&O | 18-06-2010 | 06-07-2018 | |
| Investor Relations Contact | 12-02-2009 | - | |
| President | 23-03-2011 | 06-07-2018 | |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Directeur/Bestuurslid | - | 03-08-2007 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 | 01-01-2003 |
| Algemeen Adviseur | 01-01-2000 | 01-01-2003 | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | - | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Directeur/Bestuurslid | 22-01-2015 | - |
| Independent Dir/Board Member | 22-01-2015 | - | |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Peter Traber
| University of Michigan | Undergraduate Degree |
| The Wayne State University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 13 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| President | 3 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 5 |
| Producer Manufacturing | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GALECTIN THERAPEUTICS INC. | Health Technology |
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Noble International Ltd.
 Noble International Ltd. Auto Parts: OEMProducer Manufacturing Noble International Ltd. manufactures and supplies automotive components, provides laser welding and cutting services. The company is headquartered in Troy, MI. | Producer Manufacturing |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
The University of Pennsylvania Health System
 The University of Pennsylvania Health System Miscellaneous Commercial ServicesCommercial Services The University of Pennsylvania Health System provides general patient care as well as medical education and research services. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Commercial Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
| Terrasep LLC | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
| Alacrita Consulting Ltd. |
- Beurs
- Insiders
- Peter Traber
- Ervaring
